HDFC Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1967 Cr | ₹8346 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.14 | 1.82 |
| Manager | Dhruv Muchhal | Sailesh Raj Bhan |
| ISIN Code | INF179KC1HL7 | INF204K01968 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | 1.12% | 0.82% |
| 6 Month | 7.82% | 2.4% |
| 1 Year | 6.21% | 1.06% |
| 3 Year | - | 20.88% |
| 5 Year | - | 16.43% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | 2.21% | 0.99% |
| 1 Year | 13.74% | 8.09% |
| 3 Year | - | 18.15% |
| 5 Year | - | 17.13% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 27.59% | 16.72% |
| 3 Year | - | 20.9% |
| 5 Year | - | 20.42% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 14.36% |
| Sharp | - | 0.95% |
| Beta | - | 0.87% |
| Alpha | - | 1.94% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Dhruv Muchhal | Sailesh Raj Bhan |
| Total AUM | ₹520687 Cr | ₹96086 Cr |
| Funds Managed | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 10.09 | 1.24 |
| Mid Cap | 30.15 | 35.11 |
| Small Cap | 33.66 | 31 |
| Large Cap | 26.1 | 32.65 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.71 | 0.34 |
| Basic Materials | 2.86 | - |
| Healthcare | 95.43 | 99.66 |
Top Comparisons
Tata Arbitrage Fund-Regular Plan-Growth
3Y Returns7.03%
LIC MF Arbitrage Fund Regular - Growth
3Y Returns6.7%
Kotak Floating Rate Fund-Regular Plan-Growth Option
3Y Returns7.86%
Axis Floater Fund - Regular Plan - Growth
3Y Returns7.85%
BANDHAN Bond Fund - Medium Term - Regular Plan - Growth
3Y Returns6.81%
Axis Strategic Bond Fund - Regular Plan - Growth Option
3Y Returns8.01%
Mahindra Manulife Focused Fund - Regular Plan - Growth
3Y Returns17.41%
Bandhan Focused Fund - Regular Plan - Growth
3Y Returns18.22%